Funnelfeedr Logo

Sox Therapeutics AB

Sweden559526-5900Active

Developing targeted AAV gene therapies for malignant brain tumors.

Biotechnology Companysoxtherapeutics.se

Overview

1
Employees
0 SEK
Revenue
2025
Founded

Key Decision Makers

christina herder

Board Member, Business Advisor

Mateo Santurio

Board Member, Business Advisor

FREDRIK Swartling

Chief Executive Officer, Founder, Board Member

tobias bergström

Clinical Study Lead, Clinical Study Coordinator

+4 more contacts in Funnelfeedr

Description

Sox Therapeutics is an emerging biotechnology company founded in 2025 with the primary mission of improving cancer treatment outcomes. They specialize in developing highly innovative, targeted gene therapies specifically designed for patients suffering from malignant brain tumors. Their core technol...

Tags

B2BBlue CollarHealthcareManufacturingPharmaceuticals

Keywords

AAVBiotechnologyBrain CancerDrug DevelopmentGene TherapyOncology

Company Information

Industry
Tillverkning av läkemedel
Legal Form
Aktiebolag
VAT Number
SE559526590001

Decision Makers

8 contacts in Funnelfeedr

christina herder

Board Member, Business Advisor

Mateo Santurio

Board Member, Business Advisor

FREDRIK Swartling

Chief Executive Officer, Founder, Board Member

tobias bergström

Clinical Study Lead, Clinical Study Coordinator

Other Contacts

Annika ericsson

AAV Gene Therapy Expert, CMC Drug Development

Tina LIN

Scientific Researcher, Viral Vector Design

Mats hellström

Medical Advisor, Adult Brain Tumor Treatment and Immunotherapies

sonja hutter

Co-Inventor, Scientific Advisor, Molecular Genetics and Diagnostics

Similar Companies

20 similar companies in Funnelfeedr

Browse More

Sox Therapeutics AB Questions

Want to see Funnelfeedr in action?

Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.

Book a demo